Pressure BioSciences, Inc. PBIO
Set alert
At close · Oct 29
- YTD
- 0.00%
- 1 year
- -37.50%
- Open
- 0.0398
- Prev close
- 0.0005
- Mkt cap
- 20.48K
- Vol
- 800
- Avg vol
- 5.97K
- EPS
- -0.95
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0398
- High
- 0.0398
- Forward P/E
- 0.00
- Beta
- 2.21
- Short ratio
- 3.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 4.00
- 200-d avg
- 6.37
- 1y target
- 1.57
2Y chart
Events in this range
- Dec 23, 2024Earnings: —; estimate 0; surprise —%
Signals (74)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| MACD: Sell Signal | Oct 30, 2026 | 1 day ago |
| RSI: Oversold | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 15, 2026 | 3 months ago |
| RSI: Oversold | Jul 10, 2026 | 3 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| RSI: Overbought | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 5 months ago |
| MACD: Buy Signal | May 5, 2026 | 5 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| RSI: Oversold | Apr 21, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 27, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 27, 2026 | 7 months ago |
| RSI: Overbought | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| RSI: Oversold | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 19, 2026 | 8 months ago |
| SMA: Bearish | Jan 21, 2026 | 9 months ago |
| SMA: Bullish | Jan 20, 2026 | 9 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 23, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 23, 2025 | 1 year ago |
| RSI: Overbought | Oct 23, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 2, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 29, 2025 | 1 year ago |
| SMA: Bearish | Jul 24, 2025 | 1 year ago |
| SMA: Bullish | Jul 23, 2025 | 1 year ago |
| RSI: Overbought | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 2, 2025 | 1 year ago |
| RSI: Oversold | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 11, 2025 | 1 year ago |
| RSI: Oversold | Jun 11, 2025 | 1 year ago |
| MACD: Buy Signal | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 2, 2025 | 1 year ago |
| RSI: Oversold | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 6, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 10, 2025 | 1 year ago |
| RSI: Overbought | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 21, 2025 | 1 year ago |
Key statistics
- Market cap
- 4.94M
- Enterprise value
- 14.11M
- Trailing P/E
- -1.19
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 2.41
- Price / book
- 0.00
- EPS (TTM)
- -3.77
- Beta
- 2.21
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -190.38%
- Revenue (TTM)
- 2.05M
- Revenue growth
- 5.80%
- Free cash flow
- -3.48M
- Total cash
- 201.33K
- Total debt
- 9.69M
- Return on equity
- 0.00%
- Shares outstanding
- 1.10M
- Short % of float
- 4.56%
- 50-day average
- 4.00
- 200-day average
- 6.37
Analyst view
Consensus: none
Next earnings
Dec 23, 2024
Expected Dec 23, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Sep 6, 2024 | Mar 1, 2024 | 0.00 | -0.22 | — | — |
| Jun 7, 2024 | Dec 1, 2023 | 0.00 | -0.30 | — | — |
| Nov 20, 2023 | Sep 1, 2023 | 0.00 | -0.29 | — | — |
| Aug 21, 2023 | Jun 1, 2023 | 0.00 | -0.57 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2013 | Merriman Capital | init | — | Speculative Buy |
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions in the United States. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes Constant Systems cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Appliances & Equipment
- Country
- United States
- Website
- pressurebiosciences.com
News
- Financial Comparison: NexGel (NASDAQ:NXGL) and Pressure BioSciences (OTCMKTS:PBIO)
- Head-To-Head Comparison: Pressure BioSciences (OTCMKTS:PBIO) and Artivion (NYSE:AORT)
- Head-To-Head Review: Positron (OTCMKTS:POSC) versus Pressure BioSciences (OTCMKTS:PBIO)
- Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO)
- Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray
- Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
- Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
- Pressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”
- Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.
- Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing
Your note
Sign in to keep a note on PBIO — it syncs with the Stock Master app.